{"presentation":{"slides":[{"elements":[{"x":3.476245654692932,"y":5.038715596330276,"width":93.85863267670915,"height":94.03669724770641,"action":{"library":"H5P.AdvancedText 1.1","params":{"text":"

A suggestive list of indicators for review of partnerships or private sector involvement and contribution to the NTEP is given below. You may add to the list as applicable for the specific geographical area.<\/p>\n\n

1. Notification: Total, Public, Private<\/strong><\/span> along with trendlines and with explanation of any increase or reduction in the notification. This should be done in the context of any partnerships existing or should otherwise guide the need for partnerships.<\/p>\n\n

2. List of Private Providers<\/span> <\/strong>with the list of<\/p>\n\n

a. Active providers who have ben notifying and have stopped notification for possible causes<\/p>\n\n

b. High Volume providers for planning visits\/ follow ups<\/p>\n\n

3. Indicators for the private sector vs public sector <\/strong><\/span>for various parameters related to the TB care cascade including but not limited to<\/p>\n\n

a. Notification<\/p>\n\n

b. Upfront NAAT\/ UDST \u2013 Total numbers and percentages<\/p>\n\n

c. Microbiologically confirmed cases (Percentage)<\/p>\n\n

d. Drug resistance testing \u2013 Rifampicin and Fluoroquinolone<\/p>\n\n

e. Treatment initiation \u2013 Proportion put on treatment<\/p>\n\n

i. Total put on treatment<\/p>\n\n

ii. Treatment initiated on time (7 Days)<\/p>\n\n

f. Contact tracing<\/p>\n\n

g. TPT<\/p>\n\n

h. Treatment outcomes<\/p>\n\n

i. Beneficiary payments<\/p>\n\n

i. Nikshay Poshan Yojana along with reasons for any pendence<\/p>\n\n

ii. Direct beneficiary payments<\/p>\n\n

4. Indicators related to PPSA<\/strong><\/span> functioning as mentioned in the Contracts<\/p>\n\n

5. Indicators relevant to the Partnership<\/strong><\/span> options running if any<\/p>\n"},"subContentId":"75130cdd-8e3d-422c-8135-b48ffa536f42","metadata":{"contentType":"Text","license":"U","title":"Untitled Text"}},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""}],"slideBackgroundSelector":{}},{"elements":[{"x":3.2679738562091503,"y":10.799136069114471,"width":94.77124183006536,"height":82.07343412526998,"action":{"library":"H5P.AdvancedText 1.1","params":{"text":"

d. Drug resistance testing \u2013 Rifampicin and Fluoroquinolone<\/p>\n\n

e. Treatment initiation \u2013 Proportion put on treatment including i.Total put on treatment ii.Treatment initiated on time (7 Days)<\/p>\n\n

f. Contact tracing<\/p>\n\n

g. TPT<\/p>\n\n

h. Treatment outcomes<\/p>\n\n

i. Beneficiary payments \u2013 through i. Nikshay Poshan Yojana along with reasons for any pendence ii. Direct beneficiary payments<\/p>\n\n

4. Indicators related to PPSA<\/strong><\/span> functioning as mentioned in the Contracts<\/p>\n\n

5. Indicators relevant to the Partnership<\/strong><\/span> options running if any<\/p>\n"},"subContentId":"5e8073d2-7c10-4b1b-8372-6d4022b7c046","metadata":{"contentType":"Text","license":"U","title":"Untitled Text"}},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""}],"slideBackgroundSelector":{}}],"keywordListEnabled":true,"globalBackgroundSelector":{},"keywordListAlwaysShow":false,"keywordListAutoHide":false,"keywordListOpacity":90},"override":{"activeSurface":false,"hideSummarySlide":false,"summarySlideSolutionButton":true,"summarySlideRetryButton":true,"enablePrintButton":false,"social":{"showFacebookShare":false,"facebookShare":{"url":"@currentpageurl","quote":"I scored @score out of @maxScore on a task at @currentpageurl."},"showTwitterShare":false,"twitterShare":{"statement":"I scored @score out of @maxScore on a task at @currentpageurl.","url":"@currentpageurl","hashtags":"h5p, course"},"showGoogleShare":false,"googleShareUrl":"@currentpageurl"}},"l10n":{"slide":"Slide","score":"Score","yourScore":"Your Score","maxScore":"Max Score","total":"Total","totalScore":"Total Score","showSolutions":"Show solutions","retry":"Retry","exportAnswers":"Export text","hideKeywords":"Hide sidebar navigation menu","showKeywords":"Show sidebar navigation menu","fullscreen":"Fullscreen","exitFullscreen":"Exit fullscreen","prevSlide":"Previous slide","nextSlide":"Next slide","currentSlide":"Current slide","lastSlide":"Last slide","solutionModeTitle":"Exit solution mode","solutionModeText":"Solution Mode","summaryMultipleTaskText":"Multiple tasks","scoreMessage":"You achieved:","shareFacebook":"Share on Facebook","shareTwitter":"Share on Twitter","shareGoogle":"Share on Google+","summary":"Summary","solutionsButtonTitle":"Show comments","printTitle":"Print","printIngress":"How would you like to print this presentation?","printAllSlides":"Print all slides","printCurrentSlide":"Print current slide","noTitle":"No title","accessibilitySlideNavigationExplanation":"Use left and right arrow to change slide in that direction whenever canvas is selected.","accessibilityCanvasLabel":"Presentation canvas. Use left and right arrow to move between slides.","accessibilityProgressBarLabel":"Choose slide to display","containsNotCompleted":"@slideName contains not completed interaction","containsCompleted":"@slideName contains completed interaction","slideCount":"Slide @index of @total","containsOnlyCorrect":"@slideName only has correct answers","containsIncorrectAnswers":"@slideName has incorrect answers","shareResult":"Share Result","accessibilityTotalScore":"You got @score of @maxScore points in total","accessibilityEnteredFullscreen":"Entered fullscreen","accessibilityExitedFullscreen":"Exited fullscreen","confirmDialogHeader":"Submit your answers","confirmDialogText":"This will submit your results, do you want to continue?","confirmDialogConfirmText":"Submit and see results","slideshowNavigationLabel":"Slideshow navigation"}}

Search

Suggestive List of Indicators for Partnerships Review

Content Status

Type

Linked Node

Suggestive List of Indicators for Partnerships Review

Content Creator

Reviewer

Target Audience